文献速递神经MR

DWI与高T1权重DSC-MRI预测高级别胶质瘤IDH突变状态

Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI.
PubMed 文献 · Acad Radiol · 2021-03-06

该回顾性研究纳入58例病理证实的高级别胶质瘤患者,术前行3T多参数MRI(含DSC-MRI和DWI),测量肿瘤核心平均ADC、相对最大脑血容量(rCBV)和百分比信号恢复(PSR)。IDH野生型肿瘤rCBV显著高于突变型、PSR显著低于突变型,ADC显著低于突变型但组间重叠明显;PSR诊断性能最佳(AUC 0.938,最佳截断值86.85时准确率0.87),PSR联合rCBV的AUC达0.955。作者认为DSC-MRI的rCBV和PSR可能是预测HGG IDH突变状态的无创影像参数。

要点

  • IDH野生型HGG的rCBV显著高于突变型(p=0.002),PSR显著低于突变型(p<0.001)。
  • PSR诊断IDH突变状态性能最佳,AUC 0.938,最佳截断值86.85时准确率0.87。
  • PSR联合rCBV的AUC达0.955,可提高鉴别能力。

核心结论

  • DSC-MRI的rCBV和PSR可能是预测高级别胶质瘤IDH突变状态的无创影像参数。
  • DSC灌注MRI更广泛的临床应用离不开成像方案的标准化。

研究设计与样本

  • 回顾性研究,纳入58例病理证实的高级别胶质瘤患者。
  • 所有患者术前在3T设备上行多参数MRI,包括DSC-MRI和DWI。
  • 测量肿瘤核心的平均ADC、相对最大脑血容量(rCBV)和百分比信号恢复(PSR),按IDH突变状态和肿瘤级别进行比较。
  • 采用Mann-Whitney U检验比较IDH突变型与IDH野生型HGG的参数差异,并用ROC曲线分析评估诊断性能。

诊断标准与关键数值

  • IDH野生型肿瘤rCBV显著高于IDH突变型(p=0.002),PSR显著低于IDH突变型(p<0.001)。
  • IDH野生型肿瘤ADC显著低于IDH突变型(p=0.023),但组间存在明显重叠。
  • PSR诊断性能最佳,AUC为0.938,最佳截断值86.85时准确率为0.87。
  • PSR联合rCBV鉴别IDH突变状态的AUC为0.955。
  • 按各肿瘤级别分析,PSR和rCBV在IDH突变型与IDH野生型组间均有显著差异(p≤0.001)。

临床应用与阅片要点

  • 作者认为DSC-MRI的rCBV和PSR可能是预测HGG IDH突变状态的无创影像参数。
  • 作者指出DSC灌注MRI更广泛的临床应用离不开成像方案的标准化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: We aimed to evaluate the diagnostic performance of diffusion-weighted imaging (DWI) and dynamic susceptibility contrast-enhanced (DSC) magnetic resonance imaging (MRI) parameters in the noninvasive prediction of the isocitrate dehydrogenase (IDH) mutation status in high-grade gliomas (HGGs).

MATERIALS AND METHODS: A total of 58 patients with histopathologically proved HGGs were included in this retrospective study. All patients underwent multiparametric MRI on 3-T, including DSC-MRI and DWI before surgery. The mean apparent diffusion coefficient (ADC), relative maximum cerebral blood volume (rCBV), and percentage signal recovery (PSR) of the tumor core were measured and compared depending on the IDH mutation status and tumor grade. The Mann-Whitney U test was used to detect statistically significant differences in parameters between IDH-mutant-type (IDH-m-type) and IDH-wild-type (IDH-w-type) HGGs. Receiver operating characteristic curve (ROC) analysis was performed to evaluate the diagnostic performance.

RESULTS: The rCBV was significantly higher, and the PSR value was significantly lower in IDH-w-type tumors than in the IDH-m group (p = 0.002 and <0.001, respectively).The ADC value in IDH-w-type tumors was significantly lower compared with the one in IDH-m types (p = 0.023), but remarkable overlaps were found between the groups. The PSR showed the best diagnostic performance with an AUC of 0.938 and with an accuracy rate of 0.87 at the optimal cutoff value of 86.85. The combination of the PSR and the rCBV for the identification of the IDH mutation status increased the discrimination ability at the AUC level of 0.955. In terms of each tumor grade, the PSR and rCBV showed significant differences between the IDH-m and IDH-w groups (p ≤0.001).

CONCLUSION: The rCBV and PSR from DSC-MRI may be feasible noninvasive imaging parameters for predicting the IDH mutation status in HGGs. The standardization of the imaging protocol is indispensable to the utility of DSC perfusion MRI in wider clinical usage.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Cindil E, Sendur HN, Cerit MN, et al. Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI. Acad Radiol. 2021. PMID: 33685792. doi:10.1016/j.acra.2021.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。